Dermal Cell News Volume 2.16 | May 2 2016

    0
    50

    Dermal Cell News 2.16 May 2, 2016

    Dermal Cell News

         In this issue: Publications | Reviews | Science News | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  DCN on Twitter

     
    TOP STORY
    An Oncogenic Ezh2 Mutation Induces Tumors through Global Redistribution of Histone 3 Lysine 27 Trimethylation
    Scientists described a mouse model in which the most common somatic Ezh2 gain-of-function mutation is conditionally expressed. Expression of Ezh2Y641F in mouse B cells or melanocytes caused high-penetrance lymphoma or melanoma, respectively. [Nat Med] Abstract
    Weekend-Free Culture hPSCs with mTeSRâ„¢1 or TeSRâ„¢-E8â„¢

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    DERMAL STEM CELLS & TISSUE REGENERATION

    Sex Steroids Regulate Skin Pigmentation through Nonclassical Membrane-Bound Receptors
    The authors showed that physiologic estrogen and progesterone reciprocally regulate melanin synthesis. Utilizing both genetic and pharmacologic approaches, they established that sex steroid effects on human pigment synthesis are mediated by the membrane-bound, steroid hormone receptors G protein-coupled estrogen receptor, and progestin and adipoQ receptor 7. [eLife] Abstract | Download Full Article | Press Release

    The Paracaspase MALT1 Mediates CARD14-Induced Signaling in Keratinocytes
    Investigators report that in addition to NF-κB signaling, CARD14 activates p38 and JNK MAP kinase pathways, all of which are dependent on the paracaspase MALT1. [EMBO Rep]
    Abstract | Graphical Abstract | Press Release

    EdnrB Governs Regenerative Response of Melanocyte Stem Cells by Crosstalk with Wnt Signaling
    Scientists demonstrated that the Edn/EdnrB signaling pathway can interact with other signaling pathways to elicit distinct stem cell functions during tissue regeneration. EdnrB signaling promoted proliferation and differentiation of melanocyte stem cells, dramatically enhancing the regeneration of hair and epidermal melanocytes. [Cell Rep] Full Article | Graphical Abstract | Press Release

    Alkaline Ceramidase 1 Is Essential for Mammalian Skin Homeostasis and Regulating Whole Body Energy Expenditure
    Researchers revealed the essential role of alkaline ceramidase 1 (Acer1) in the skin. They demonstrated that Acer1 is specifically expressed in differentiated interfollicular epidermis, infundibulum and sebaceous glands and consequently Acer1−/− mice have significant alterations in infundibulum and sebaceous gland architecture. Acer1−/− skin also showed perturbed hair follicle stem cell compartments. [J Pathol] Abstract

    Activating Hair Follicle Stem Cells via R-Spondin2 to Stimulate Hair Growth
    The authors showed that Wnt signaling is elevated during anagen, is reduced at the onset of catagen, and can be re-amplified in the skin and surrounding hair follicles via intradermal injection of recombinant R-Spondin2 protein. [J Invest Dermatol] Abstract

    Paracrine Factors from Irradiated Peripheral Blood Mononuclear Cells Improve Skin Regeneration and Angiogenesis in a Porcine Burn Model
    Investigators hypothesized that topical application of the peripheral blood mononuclear cells secretome would improve the quality of regenerating skin, increase angiogenesis, and reduce scar formation after burn injury and skin grafting in a porcine model. [Sci Rep] Full Article

    SKIN CANCERS & DISORDERS

    The Barrier Function of Organotypic Non-Melanoma Skin Cancer Models
    Researchers investigated the molecular basis for the impaired skin barrier function of organotypic non-melanoma skin cancer models. They unraveled disturbed epidermal differentiation by reflectance confocal microscopy and histopathological evaluation. [J Control Release] Abstract

    Oncostatin M Overexpression Induces Skin Inflammation but Is Not Required in the Mouse Model of Imiquimod-Induced Psoriasis-Like Inflammation
    The authors showed that oncostatin M potently regulates the expression of genes involved in skin inflammation and epidermal differentiation in murine primary keratinocytes. [Eur J Immunol] Abstract

    TGF-β Induces SOX2 Expression in a Time-Dependent Manner in Human Melanoma Cells
    Researchers observed high expression of sry-related high-mobility box (SOX)-2 in both human melanoma cell lines and primary melanomas in contrast to melanocytic nevi. This overexpression in melanoma can, in part, be explained by extra gene copy numbers of SOX2 in primary samples. [Pigment Cell Melanoma Res] Abstract

    Cryopreservation Media for Stem Cells - Learn More!

     
    REVIEWS
    From Melanocytes to Melanomas
    The authors delineate several of the more common progression trajectories that occur in the patient setting and proposes models for tumor evolution that integrate genetic, histopathological, clinical and biological insights from the melanoma literature. [Nat Rev Cancer] Abstract

    Visit our reviews page to see a complete list of reviews in the dermal cell research field.

     
    SCIENCE NEWS
    Heat Biologics and OncoSec Present Data
    Heat Biologics, Inc. announced that preclinical data from its collaboration with OncoSec Medical Incorporated focused on evaluating the combination of immunotherapy platforms were presented. [Press release from Heat Biologics, Inc. discussing research presented at the 2016 American Association for Cancer Research (AACR) Annual Meeting, New Orleans] Press Release

    New wallchart from our sponsor:
    Mesenchymal Stem Cells (a Nature Reviews Molecular Cell Biology collaboration).
    Request your free copy.

     
    INDUSTRY NEWS
    Cipher Pharmaceuticals Acquires Worldwide Rights to Dalhousie University’s Investigational Tattoo Removal Cream
    Cipher Pharmaceuticals Inc. announced it has licensed the worldwide rights to develop and commercialize an investigational tattoo removal cream being developed at Dalhousie University in Halifax, Nova Scotia by Alec Falkenham, a PhD student in the Department of Pathology at Dalhousie University. [Cipher Pharmaceuticals Inc.] Press Release

    Largest Independent U.S. Psoriasis Registry to Track Safety of New Biologic Treatment
    The Corrona Psoriasis Registry announced it will track the drug safety reporting for ixekizumab, a new biologic medication by Eli Lilly and Company that was recently approved for the treatment of moderate-to-severe plaque psoriasis. [The Corrona Psoriasis Registry (PR Newswire Association LLC.)] Press Release

     
    POLICY NEWS
    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW Worldwide Innovative Networking in Personalized Cancer Medicine (WIN) 2016
    June 27-28, 2016
    Paris, France

    Visit our events page to see a complete list of events in the dermal cell community.

     
    JOB OPPORTUNITIES
    NEW Postdoctoral Positions – Immunology, Cancer, and Stem Cells (University of Connecticut)

    NEW Postdoctoral Research Fellow – Microbiota, T cells, and Transplantation (Fred Hutchinson Cancer Research Center)

    Postdoctoral Position – Cancer Biology/Immunology (The University of Texas MD Anderson Cancer Center)

    Postdoctoral Scientist – Molecular Oncology Group (Cancer Research UK Manchester Institute)

    Faculty Position – Tumor Immunology (John Wayne Cancer Institute at Providence Saint John’s Health Center)

    Postdoctoral Position – Stem Cell Biology and Tissue Engineering (Northeastern University)

    Skincare Applied Research Manager (L’Oreal)

    Postdoctoral Research Fellow – Cancer and Inflammatory Diseases of the Skin (Weill Cornell Medical College)

    Postdoctoral Positions – Tissue Repair/Inflammation (Institut Pasteur)

    Research Technician – Tumor Initiation and Metastasis (Fred Hutchinson Cancer Research Center)


    Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Dermal Cell News? Click here to submit!

    Comments or suggestions? Submit your feedback here

    Learn more about Dermal Cell News: Archives | Events | Contact Us